FibroBiologics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2021 | — | $-1.3M | $407.0K |
| Dec 2022 | — | $-4.0M | $2.3M |
| Mar 2023 | — | $639.0K | $14.7M |
| Jun 2023 | — | $11.4M | $11.4M |
| Sep 2023 | — | $10.5M | $10.8M |
| Dec 2023 | — | $1.3M | $9.2M |
| Mar 2024 | — | $-3.9M | $8.2M |
| Jun 2024 | — | $-2.4M | $6.0M |
| Sep 2024 | — | $2.7M | $7.8M |
| Dec 2024 | — | $2.7M | $14.0M |
| Mar 2025 | — | $2.4M | $8.7M |
| Jun 2025 | — | $860.0K | $8.8M |
| Sep 2025 | — | $125.0K | $4.9M |
| Dec 2025 | — | $6.2M | $4.9M |
| Mar 2026 | — | $2.6M | $1.5M |
| Jun 2026 | — | $4.6M | $3.5M |